| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 0.71 |
—
|
| 2025 | 0.83 |
—
—
|
| 2024 | 0.73 |
—
—
|
| 2023 | 0.51 |
—
—
|
| 2022 | 0.37 |
—
—
|
| 2021 | 0.16 |
—
—
|
| 2020 | 0.17 |
—
|
| 2019 | 0.29 |
—
—
|
| 2018 | 0.30 |
—
—
|
| 2017 | 0.33 |
—
—
—
|
| 2016 | 0.41 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 234,271.40 | 173,236.60 | 205,939.70 | 254,294.10 |
| Receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 669,649.30 | 173,236.60 | 205,939.70 | 898,341.60 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 512,831.60 | 632,313.30 | 745,138.90 | 694,596.90 |
| ST’ Debt | — | — | — | — |
| Other | 146,125.60 | 109,879.70 | 124,831.90 | 154,828.60 |
| 659,907.50 | 742,815.10 | 871,645.30 | 851,384.70 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 12,467.10 | 12,215.33 | — | — |
—
|
| ’25 | 9,821.78 | 9,887.59 | 10,640.50 | 11,432.73 |
41,782.60
|
| ’24 | 8,923.37 | 9,935.48 | 9,585.21 | 9,951.01 |
38,395.07
|
| ’23 | 7,468.72 | 7,838.89 | 8,660.40 | 8,005.30 |
31,973.30
|
| ’22 | 7,258.68 | 6,486.30 | 6,905.36 | 5,572.71 |
26,223.05
|
| ’21 | 6,213.66 | 6,149.81 | 6,285.14 | 6,274.58 |
24,923.19
|
| ’20 | 7,152.05 | 6,123.22 | 6,618.88 | 6,349.06 |
26,243.20
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (11,423.10) | 26,521.92 | — | — |
—
|
| ’25 | 165.40 | (7,212.72) | 19,860.80 | 4,121.31 |
16,934.79
|
| ’24 | (209.54) | (28,972.30) | 16,547.44 | (7,049.00) |
(19,683.40)
|
| ’23 | 931.52 | (8,181.27) | (4,671.65) | 12,072.58 |
(780.34)
|
| ’22 | 3,764.44 | 21,795.88 | 29,949.51 | 24,989.29 |
24,989.29
|
| ’21 | (10,814.23) | (1,648.05) | 15,300.00 | (1,469.41) |
(1,469.41)
|
| ’20 | — | 30,119.49 | 24,954.12 | 44,948.36 |
44,948.36
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (11,938.08) | 25,954.42 | — | — |
—
|
| ’25 | (159.08) | (7,647.69) | 19,328.62 | 3,463.54 |
14,985.39
|
| ’24 | (651.42) | (29,480.25) | 15,993.01 | (7,608.31) |
(21,746.96)
|
| ’23 | 931.52 | (9,020.88) | (5,408.04) | 11,779.45 |
(2,649.47)
|
| ’22 | 3,764.44 | 19,966.52 | 29,949.51 | 22,446.95 |
22,446.95
|
| ’21 | (10,962.52) | (1,814.24) | 15,300.00 | (2,496.34) |
(2,496.34)
|
| ’20 | — | 29,825.50 | 24,954.12 | 44,302.96 |
44,302.96
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.60 | 0.62 | — | — |
—
|
| ’25 | 0.47 | 0.52 | 0.49 | 0.49 |
1.99
|
| ’24 | 0.39 | 0.51 | 0.48 | 0.43 |
1.82
|
| ’23 | 0.31 | 0.36 | 0.36 | 0.36 |
1.40
|
| ’22 | 0.27 | 0.27 | 0.28 | 0.25 |
1.04
|
| ’21 | 0.21 | 0.11 | 0.24 | 0.23 |
0.79
|
| ’20 | (0.32) | 0.09 | 0.19 | 0.21 |
0.16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 3.93 | 6.15 | 8.63 | 9.44 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 6.97 | 9.52 | 12.20 | 23.59 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 115,675 | 121,486 | 125,916 | 127,174 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.23 | 0.26 | 0.30 | 0.33 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26,223.05 | 31,973.30 | 38,395.07 | 41,782.60 | — | — | — |
Revenue
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 100.00% | 100.00% | 100.00% | 100.00% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11,052.26 | 13,441.08 | 16,669.75 | 18,359.23 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.15% | 42.04% | 43.42% | 43.94% | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,192.93 | 9,108.64 | 11,443.21 | 12,587.96 | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,399.18 | 1,518.47 | 1,658.86 | 1,720.86 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.24 | 5.37 | 6.66 | 7.27 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 1.04 | 1.40 | 1.82 | 1.99 | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.04 | (0.13) | (3.41) | 2.95 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.41) | (0.31) | (0.36) | (0.34) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.63 | (0.44) | (3.77) | 2.61 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.62 | 10.05 | 11.26 | 12.16 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,189.00 | 5,954.00 | 5,769.00 | 5,748.00 | — | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.77 | 6.62 | 5.37 | 11.83 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.46 | 1.71 | 1.46 | 3.21 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.72 | 0.92 | 0.86 | 1.92 | — | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.27) | 0.18 | 1.91 | 2.88 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.45) | (1.32) | (3.38) | 8.03 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24,989.29 | (780.34) | (19,683.40) | 16,934.79 | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2,542.34) | (1,869.13) | (2,063.56) | (1,949.40) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22,446.95 | (2,649.47) | (21,746.96) | 14,985.39 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,277.90 | 9,741.80 | (569,578.50) | (665,705.60) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 129,052.13 | 74,361.59 | 75,603.08 | 92,596.04 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (71,581.77) | (159,909.81) | (97,633.52) | (113,343.66) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 53,327.96 | 59,813.31 | 64,941.15 | 69,918.26 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.91% | 1.09% | 1.30% | 1.27% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.57% | 15.34% | 17.44% | 16.97% | — | — | — |
ROE
|
Banco Bilbao Vizcaya Argentaria (BBVA) has staged a impressive post-COVID recovery, leveraging higher-for-longer interest rates in Europe and Latin America to drive record earnings, with revenue climbing at a 4.4% CAGR to €38.4 billion in 2024 and ROE surging to 17.4%—well above European banking peers. Its dominant Mexican franchise (via BBVA Bancomer) has fueled much of this growth amid nearshoring tailwinds, while efficiency gains pushed revenue per employee to €304,926 and EBT margins to 43.4%. Yet, as a risk-averse observer, I note the balance sheet’s strength, with expanding shareholders’ equity to €64.9 billion and negative net debt signaling ample liquidity buffers against LatAm volatility.
Cash flow remains BBVA’s soft spot, swinging wildly from €44.9 billion in 2020 to -€19.7 billion in 2024 due to working capital swings tied to loan expansion— a cyclical banking hallmark that tempers enthusiasm despite solid ROA and undervalued multiples (PE at 5.4x, PB at 0.86x). Analyst targets imply 13% upside from recent levels, supported by projected 9-10% revenue and EBT growth in 2025, but downside risks loom from ECB rate cuts compressing NIMs, regulatory hurdles post the failed Sabadell bid, and geopolitical tremors in Mexico and Argentina.
Trading at a discount to its earnings power, BBVA offers appeal for steady performers, but volatile cash flows and macro headwinds warrant a cautious hold-to-buy on dips. The full analysis delves deeper into these trends, valuations, and execution risks to assess if the upside justifies the uncertainties.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.